Scholars Central

Search Scholars Central

Articles, journals and conferences in one search. An exact title, DOI or ISSN is listed first.

Advanced searchHide advanced search

In the search box: "exact phrase" · -leave out · OR · prefix* · title: author: journal:

Years

1–25 of 62 articles for Lenalidomide

Then save them, add them to a collection or cite them together.
  1. Research article · 2016

    Pharmacokinetic Comparison and Bioequivalence of a New Generic Formulation of Lenalidomide 25 mg Capsules versus Revlimid in Healthy Volunteers under Fasting Conditions

    Journal of Bioequivalence & Bioavailability · Volume 8, Issue 5

    Lenalidomide is an immunomodulatory agent with direct antiproliferative, proapoptotic, and antiangiogenic effects, combined with long-term immunostimulatory effects which improve both cellular and humoral immune…

  2. Review article · 2013

    Lenalidomide Therapy of Myelodysplastic Syndromes

    Journal of Leukemia · Volume 1, Issue 1

    less often to erythroblastic stimulating agents. However, immunomodulatory, anti-cytokine, and anti-angiogenic agent Lenalidomide (CC5013, Revlimid®) leads to red blood cells transfusion independence of low risk MDS…

  3. Article · 14 Feb 2019

    Biopharmaceutics Classification System (BCS) Based Biowaiver Studies of Lenalidomide Capsules (25 mg) andndash; An Alternative to In vivo Bioequivalence Studies for Generic Oncology Drug Products

    Journal of Bioequivalence & Bioavailability · Volume 11, Issue 1

    Lenalidomide, commercialized as Revlimid®, is an immunomodulatory drug, approved as a therapy for Multiple Myeloma and deletion 5q Myelodysplastic syndromes. This molecule shows a promising therapeutic potential in…

  4. Research article · 2015

    Lenalidomide Polarizes Th1-specific Anti-tumor Immune Response and Expands XBP1 Antigen-Specific Central Memory CD3+CD8+ T cells against Various Solid Tumors

    Journal of Leukemia · Volume 3, Issue 2

    tumor cells overexpressing XBP1 target antigen were evaluated, either alone or in combination with lenalidomide, for phenotype and immune functional activity. Results: Lenalidomide treatment of XBP1-CTL increased the…

  5. Research article · 7 Sep 2022

    Development and Validation of Gas Chromatography Method for the Determination of 2,2?-Azobisisobutyronitrile and Di-tertiary Butyl Dicarbonate Contents in Lenalidomide Drug Substance

    Der Pharma Chemica · Volume 13, Issue 11

    Azobis-Iso-Butyro-Nitrile (AIBN) and Ditertiary Butyl dicarbonate (DIBOC) in Lenalidomide [LEN] drug substance. Efficient chromatographic separation was achieved on SPB-1, 30 m long with

  6. Conference abstract · 13 Jul 2017

    LC–MS/MS method for simultaneous determination of thalidomide, lenalidomide, cyclophosphamide, bortezomib, dexamethasone and adriamycin in serum of multiple myeloma patients

    Journal of Chromatography & Separation Techniques

    human health. The determination of 6 commonly used drug concentrations, including thalidomide (THD), lenalidomide (LND), cyclophosphamide (CTX), bortezomib (BTZ), dexamethasone (DXM) and adriamycin (ADM), in MM patients…

  7. Research article · 31 Aug 2020

    Pharmacology 2020: Investigating the effects of the anti-cancer drug Elotuzumab on human multiple myeloma cell lines MM1S and H929 - MARIE BANGURA - University of Westminster

    International Research Journal of Pharmacy and Pharmacology · Volume 8, Issue 3

    ABSTRACT A series of experiments were carried out using Elotuzumab, lenalidomide, and dexamethasone on MM.1S and H929 myeloma cell lines to test their efficacy in vitro and to develop ... that binds specifically to the…

For authors and organisers

Publish, present and keep up with your field

Find the right journal for your paper and submit your manuscript.

Photo: Pexels